• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>T. Rowe Price Health Sciences

T. Rowe Price Health Sciences

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. UPDATE: Health-care fund manager with 20% gain this year sees good times ahead as FDA becomes 'more accommodating'

    UPDATE: Health-care fund manager with 20% gain this year sees good times ahead as FDA becomes 'more accommodating'

  2. UPDATE: Health-care fund manager with 20% gain this year sees good times ahead as FDA becomes 'more accommodating'

    UPDATE: Health-care fund manager with 20% gain this year sees good times ahead as FDA becomes 'more accommodating'

  3. UPDATE: Health-care fund manager with 20% gain this year sees good times ahead as FDA becomes 'more accommodating'

    UPDATE: Health-care fund manager with 20% gain this year sees good times ahead as FDA becomes 'more accommodating'

  4. UPDATE: Health-care fund manager with 20% gain this year sees good times ahead as FDA becomes 'more accommodating'

    UPDATE: Health-care fund manager with 20% gain this year sees good times ahead as FDA becomes 'more accommodating'

  5. UPDATE: Fund manager with 20% gain this year sees good times ahead as FDA becomes 'more accommodating'

    UPDATE: Fund manager with 20% gain this year sees good times ahead as FDA becomes 'more accommodating'

  6. How Fund Companies Stack Up in Our Analyst Ratings

    Stepping back to see the forest for the trees.

  7. T. Rowe Price Thrives Despite a Tumultuous 2013

    The firm remains on solid footing after some unexpected manager and analyst departures.

  8. T. Rowe Price Remains on Top

    Departures of investment staff are worth watching, though.

  9. How Do T. Rowe Price Funds Stack Up?

    Most of the firm's rated funds have garnered positive Morningstar Analyst Ratings.

©2017 Morningstar Advisor. All right reserved.